Image de couverture de livre

Spinal Muscular Atrophy Carrier Screening: Assessment of Provider Knowledge and Clinical Practice

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Melissa Riegel, Whitney Bender, Elizabeth Critchlow, Lorraine Dugoff
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Prenatal Diagnosis
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Type 0 Spinal Muscular Atrophy Detected by Prenatal Exome Sequencing: Towards a Recognizable Fetal Phenotype
par: M. Codina‐Solà, et autres
Publié: (2026)

The Intersection Between Genetic Reproductive Carrier Screening and Genomic Newborn Screening: Implications for Clinical Practice
par: Lilian Downie, et autres
Publié: (2025)

Prenatally Diagnosed Beare‐Stevenson Cutis Gyrata Syndrome With a Novel FGFR2 Variant
par: Haley M. Crane, et autres
Publié: (2026)

Disparities in Prenatal Carrier Screening Including Partner Testing by Insurance Status
par: Spencer C. Darveau, et autres
Publié: (2026)

Blazing the Trail of Non‐Invasive Prenatal Screening Expanded Use: Healthcare Providers' Perspectives
par: Tierry M. Laforce, et autres
Publié: (2025)

Incidental Identification of Potentially Affected Individuals Through Expanded Carrier Screening During Preconception or Early Pregnancy
par: Yan Lü, et autres
Publié: (2025)

‘I Could Trust It’: Experiences of Reciprocal Translocation Carriers and Their Partners With Prenatal Cell‐Free DNA Screening for Unbalanced Translocations
par: Marta Cifuentes Ochoa, et autres
Publié: (2024)

Evolving Practices in Prenatal Open Spinal Dysraphism: A Global Survey of Selection Criteria, Surgical Techniques, and Diagnostic Trends
par: Corinna Keil, et autres
Publié: (2025)

Clinical Utility of Nuchal Translucency Measurement in First‐Trimester Ultrasound Screening in a Setting With First‐Tier NIPT for Aneuploidy Screening
par: Eline E. R. Lust, et autres
Publié: (2025)

Prenatal Phenotype of Alkuraya‐Kučinskas Syndrome: A Novel Case and Systematic Literature Review
par: Stephanie M. Rice, et autres
Publié: (2024)

Screening Positive for Rare Autosomal Aneuploidies Increases Frequency of Adverse Pregnancy Outcomes and Alters Clinical Management
par: Devika Chawla, et autres
Publié: (2025)

Uncovering the Genetic Landscape of Spinal Dysraphism: A Retrospective Analysis of 150 Fetal Cases
par: I. Bedei, et autres
Publié: (2025)

Correspondence on “Current Controversy in Prenatal Diagnosis: The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”
par: Julia Wynn, et autres
Publié: (2024)

Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies
par: Susan Hancock, et autres
Publié: (2026)

Reassurance‐Focused First‐Trimester Euploidy Screening With Machine Learning
par: Paula Idalia Szenejko, et autres
Publié: (2026)

Quality of Evidence for Prenatal Down Syndrome Screening: An Umbrella Review
par: Yuehua Zhang, et autres
Publié: (2026)

Screening and Predictive Biomarkers for Down Syndrome Through Amniotic Fluid Metabolomics
par: Li‐Chao Zhang, et autres
Publié: (2024)

Evaluating How Beliefs Among Pediatric Cardiology Providers May Affect Fetal Cardiac Counseling—A National Perspective
par: Caitlin S. Haxel, et autres
Publié: (2024)

Response to the Correspondence by Jean‐Marie Jouannic et al. to: Prenatal Diagnosis and Postnatal Outcome of Closed Spinal Dysraphism. Prenat Diagn. 2024 Apr;44(4):499–510
par: Ivonne Bedei, et autres
Publié: (2024)

Theoretical Performance of Comprehensive Non‐Invasive Prenatal Screening in Congenital Heart Defects
par: Emily Yang, et autres
Publié: (2026)

Reproductive Decision‐Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing
par: Marta D'Alonzo, et autres
Publié: (2026)

Diagnostic Yield of Serial PR Interval Screening for Fetal Heart Block in Anti‐SSA/SSB Pregnancies
par: Alyssa Yeung, et autres
Publié: (2026)

First‐Trimester Down Syndrome Screening in Renal‐Transplanted Pregnant Women: Blood Creatinine Levels Impact False‐Positive Rate
par: Clément Burgy, et autres
Publié: (2026)

Utility of Fluorescence In Situ Hybridization as a Fetal Surgery Eligibility Criterion for Isolated Congenital Anomalies When Non‐Invasive Screening Is Performed
par: Ethan Lorence, et autres
Publié: (2026)

Artifacts, Not Differences in Sex Development, Are the Predominant Cause of Phenotypic Sex Discordance With Prenatal Cell‐Free DNA Screening: A Review of 33 Cases
par: Qiliang Ding, et autres
Publié: (2025)

Single‐Step Universal First‐Trimester Cytomegalovirus Screening and Valacyclovir Prophylaxis in Pregnancy: A Cost‐Utility Analysis in a High Seroprevalence Setting
par: Zhi Zhen Lim, et autres
Publié: (2025)

The Importance of Clinical Acumen for Prenatal Diagnosis in an Increasingly Technological World
par: Teresa N. Sparks, et autres
Publié: (2025)

Clinically Significant Genetic Results in Fetuses With Isolated Horseshoe Kidney
par: Qiu‐Xia Yu, et autres
Publié: (2026)

Genetic Diagnosis and Clinical Features of Fetuses With Congenital Diaphragmatic Hernia
par: Yan Lü, et autres
Publié: (2024)

Combined Cell‐Free DNA Screening for Aneuploidies and Selected Single‐Gene Disorders for Pregnancies With Sonographically Detected Fetal Anomalies: Detection Rate and Residual Risk
par: Thi Lan Anh Luong, et autres
Publié: (2024)

Is It Feasible to Screen for Fetal De Novo or Paternally Inherited Pathogenic Single Nucleotide Variants in Maternal Plasma Cell‐Free DNA? A Systematic Literature Review
par: Kristína Valovičová, et autres
Publié: (2025)

Prenatal Screening for Fetal X‐Linked Ichthyosis: A Large Cohort Study Combining Non‐Invasive Prenatal Testing and Maternal Serum Unconjugated Estriol Analysis
par: Miao Han, et autres
Publié: (2026)

Clinical Characteristics and Outcomes of Intrauterine Blood Transfusion (IUT) for Infectious Etiologies
par: Jessian L. Munoz, et autres
Publié: (2024)

A Practical Prenatal Ultrasound Classification System for Lower Limb Anomalies—PRELLIM Classification
par: Arda Arduç, et autres
Publié: (2025)

Improving the Performance of Prenatal Cell‐Free DNA Screening Through Size‐Selective Fetal DNA Enrichment in a Cohort of 71,986 General and High‐Risk Pregnancies
par: Liang Hu, et autres
Publié: (2025)

Neurocognitive Assessment in Children With Prenatal Diagnosis of Apparently Isolated Obliteration of Cavum Septi Pellucidi
par: Elisa Montaguti, et autres
Publié: (2025)

Clinical and Molecular Features of Ciliopathies Diagnosed by Prenatal Exome Sequencing in Fetuses With Ultrasound Abnormalities
par: Xiaofan Zhu, et autres
Publié: (2025)

Persistent Uninterpretable or Failed Prenatal Cell‐Free DNA Screening Indicates a High‐Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA‐Analysis: A Prospective Cohort Study
par: L. Lannoo, et autres
Publié: (2025)

Prenatal Exome Sequencing Analysis in Fetuses With Structural Anomalies: A Multicenter Prospective Cohort Study With Practical Implications
par: Yulin Jiang, et autres
Publié: (2025)

Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases
par: Antonino Giambona, et autres
Publié: (2026)